drugset / Trial / NCT01919190

EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries

NCT01919190 ↗

Phase 4 Terminated 67 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this prospective, blinded assessor, randomized trial is to assess opioid use and patient-reported outcomes of EXPAREL as a foundation in postsurgical pain therapy in Transversus Abdominis Plane (TAP) infiltration in lower abdominal surgical procedures.

Timeline

Start
2013-08
Primary completion
2013-12
Completion
2014-02

Outcome

Outcome not reported

Stopped: “Due to reasons unrelated to safety; primary endpoint signal seen during pre-specified interim analysis.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.